Focused Cardiac Ultrasound in Surgery (PreOPFOCUS)

April 27, 2021 updated by: Jan Pallesen, Aarhus University Hospital

The Effects of Pre-operative Point-of-Care Focused Cardiac Ultrasound on Patient Outcome - a Prospective, Randomized, Clinical Study (PreOPFOCUS)

Mortality and morbidity remain high after non-cardiac surgery. Known risk factors include age, high ASA grade and emergency surgery. Point-of-care focused cardiac ultrasound may elucidate pathology and potential hemodynamic compromise unknown to handling physicians. This study aims to investigate the effects of focused cardiac ultrasound in high-risk patients undergoing non-cardiac surgery with respect to clinical endpoints.

Study Overview

Detailed Description

In non-cardiac surgery major risk factors for morbidity and mortality include ASA classification, age, acute surgery and pre-existing cardiopulmonary disease. These risk factors are sometimes readily available and, along with the type of surgery, allow anaesthesiologists to tailor anaesthetic drugs, fluid therapy and monitoring to the individual patient need. However, cardiopulmonary disease may be occult or masked by other patient-related incapacities. Hence, identification of cardiopulmonary disease is an important priority during the pre-operative anaesthesia evaluation. Routine pre-operative anaesthesia evaluation includes screening with auscultation, blood tests and often electrocardiography. However, these exams are insensitive for detecting cardiopulmonary diseases that may be life threatening during anaesthesia, including ischaemia, heart valve disease and left ventricular hypertrophy.

Point-of-care focused cardiac ultrasound (FOCUS) is claimed to be an effective method for filling out this obvious gap in rapid diagnostic capability, as FOCUS can detect both structural and functional cardiac disease as well as pleural effusion. FOCUS performed by anaesthesiologists can identify unknown pathologies in surgical patients and identification of these enables prediction of perioperative morbidity. Although pre-operative FOCUS has been shown to alter anaesthetic patient management, it remains unclear whether the application of FOCUS actually impacts patient outcome.

This study aims to clarify whether pre-operative FOCUS changes clinical outcomes in high-risk patients undergoing acute, non-cardiac surgery.

The hypothesis of the study is that pre-operative FOCUS reduces the fraction of patients admitted to hospital for more than 10 days or are dead within 30 days after high risk, non-cardiac surgery.

Study Type

Interventional

Enrollment (Actual)

337

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Randers, Denmark
        • Department of Anaesthesiology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients scheduled for emergency (< 6 hours) or urgent surgery (< 24 hours)15
  • General or neuro-axial anaesthesia planned at the first anesthetic visit
  • ASA classification 3 or 4.
  • Age ≥ 65 years

Exclusion Criteria:

  • Previous surgery performed during current hospital admission (including transfers from other hospitals than Randers Regional Hospital/Hospital of Southern Jutland)
  • Low risk surgery or expected surgery time < 30 minutes or endoscopies.
  • Lack of consent from patient or proxy (in case of patient mental incapacity)
  • Previous participation in the study. Pre-operative FOCUS not possible for logistical reasons or due to requirement for immediate surgery

Drop-out Criteria:

Patients who refuse participation after formal inclusion will drop out.

• Patients converted from a primary anaesthetic plan of general/neuro-axial anaesthesia to regional anaesthesia will not drop-out. -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: FOCUS (focused cardiac ultrasound)
Patients allocated to FOCUS will receive a preoperative FOCUS examination in conjunction with a standard anesthetic preoperative evaluation.

A ultrasound of the heart and pleura will be performed. This provide information on

  • Left ventricular systolic function
  • Left ventricular diastolic function
  • Right ventricular systolic function
  • Right ventricular pressure overload
  • Biventricular sizes
  • Pathology of the mitral- and aortic valves
  • Pericardial fluid
  • Gross fluid status
  • Pleural effusion
No Intervention: Control
Patients allocated til control arm will receive a standard anesthetic preoperative evaluation according to hospitals' standards.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Proportion of patients admitted to hospital ≥ 10 days or dead within 30 days
Time Frame: 30 days after surgery
30 days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of stay
Time Frame: Up to 180 days after surgery
Defined as the number of days admitted to hospital from the date of surgery (included)
Up to 180 days after surgery
Re-admissions to hospital
Time Frame: Up to 90 days after surgery
Re-admissions to hospital (no) within 90 days (no)
Up to 90 days after surgery
Length of stay
Time Frame: Up to 90 days after surgery
Length of stay including re-admissions to hospital within 90 days
Up to 90 days after surgery
Death ≤ 30 days & ≤ 90 days
Time Frame: Up to 90 days after surgery
Death ≤ 30 days & ≤ 90 days (no)
Up to 90 days after surgery
Intensive care treatment
Time Frame: Up to 90 days after surgery
Intensive care treatment (hours)
Up to 90 days after surgery
Postoperative ventilator treatment
Time Frame: Up to 90 days after surgery
Postoperative ventilator treatment (hours)
Up to 90 days after surgery
Admittance to the post-operative care unit
Time Frame: Up to 1 day after surgery
Admittance to the post-operative care unit (hours)
Up to 1 day after surgery
Development of acute kidney injury
Time Frame: Within 7 days of surgery
Development of acute kidney injury (AKI) (stage 1,2 & 3, defined by th KDIGO creatinine criteria within seven days of surgery)
Within 7 days of surgery
Accumulated intra- and postoperative infusion of norepinephrine, epinephrine, phenylephrine, ephedrine, dobutamine, dopamine and other vasoactive drugs.
Time Frame: From start of anaesthesia til end of anaesthesia
Accumulated intra- and postoperative infusion of norepinephrine, epinephrine, phenylephrine, ephedrine, dobutamine, dopamine and other vasoactive drugs (mg).
From start of anaesthesia til end of anaesthesia
Accumulated fluid balance
Time Frame: From start of anaesthesia til end of anaesthesia
Accumulated fluid balance until end of surgery
From start of anaesthesia til end of anaesthesia
Echocardiography
Time Frame: From anaeshetic visit to start of anaesthesia
Formal echocardiography's (1) ordered and (2) actually performed in total and secondarily due to preoperative FOCUS (no).
From anaeshetic visit to start of anaesthesia
Surgery cancellations due to preoperative FOCUS
Time Frame: Before start of anaeshesia
Surgery cancellations in total and secondarily due to preoperative FOCUS (no)
Before start of anaeshesia
Surgery postponements due to preoperative FOCUS
Time Frame: Within 7 days of preoperative anaesthetic visit
Surgery postponements in total and secondarily due to preoperative FOCUS (no).
Within 7 days of preoperative anaesthetic visit
Surgery changes
Time Frame: From FOCUS to the start of surgery
Surgery changes in total and secondarily due to preoperative FOCUS (no, type).
From FOCUS to the start of surgery
Perioperative myocardial damage
Time Frame: From the day before surgery to the day following surgery
Troponin I
From the day before surgery to the day following surgery
Changes in anesthetic practice
Time Frame: From start of anaesthesia to start of surgery
Changes in anesthetic practice/perianesthetic care DUE to preoperative FOCUS. Includes both step up/step down
From start of anaesthesia to start of surgery
Echocardiography
Time Frame: From FOCUS to start of surgery
Formal echocardiographies ordered prior to surgery
From FOCUS to start of surgery
Volume
Time Frame: From FOCUS to the start of anaesthesia
Volume infusion prior to anesthesia. Both in total and facilitated by FOCUS
From FOCUS to the start of anaesthesia
Anaesthesia type
Time Frame: From FOCUS to the start of anaesthesia
Conversion of Anaesthesia type from primary anesthetic visit to actually performed. Both in total and facilitated by FOCUS.
From FOCUS to the start of anaesthesia
Anaesthetic monitoring
Time Frame: From start of anaesthesia to end of anaesthesia
Step up and step down in anesthetic monitoring. Both in total and facilitated by FOCUS. Includes extra intravenous lines inserted including central venous catheters, arterial lines inserted, change to 5-lead ECG, vasopressors infused with anaesthetic induction
From start of anaesthesia to end of anaesthesia
Anesthesia time
Time Frame: From start of anaesthesia to end of anaesthesia
Anesthesia time
From start of anaesthesia to end of anaesthesia
Surgery time
Time Frame: From start of surgery to end of surgery
Surgery time
From start of surgery to end of surgery
Cardiogenic pulmonary oedema
Time Frame: From start of anaesthesia to 30 days after surgery
Cardiogenic pulmonary oedema within 30 days of surgery
From start of anaesthesia to 30 days after surgery
New onset cardiac arrhythmia
Time Frame: From start of anaesthesia to 30 days after surgery
New onset cardiac arrhythmia of any kind.
From start of anaesthesia to 30 days after surgery
Non-fatal cardiac arrest
Time Frame: From start of anaesthesia to 30 days after surgery
Non-fatal cardiac arrest regardless of cause.
From start of anaesthesia to 30 days after surgery
Anastomotic breakdown
Time Frame: From start of anaesthesia to 30 days after surgery
Anastomotic breakdown (deep or superficial)
From start of anaesthesia to 30 days after surgery
Myocardial infarction
Time Frame: From start of anaesthesia to 30 days after surgery
Myocardial infarction as defined by the universal criteria
From start of anaesthesia to 30 days after surgery
Stroke
Time Frame: From start of anaesthesia to 30 days after surgery
Cerebral stroke
From start of anaesthesia to 30 days after surgery
Pulmonary embolism
Time Frame: From start of anaesthesia to 30 days after surgery
Pulmonary embolism with radiological confirmation
From start of anaesthesia to 30 days after surgery
Postoperative haemorrhage
Time Frame: From end of anaesthesia to 30 days after surgery
Postoperative haemorrhage demanding blood transfusion
From end of anaesthesia to 30 days after surgery
Gastrointestinal bleed
Time Frame: From start of anaesthesia to 30 days after surgery
Gastrointestinal bleed
From start of anaesthesia to 30 days after surgery
Pneumonia
Time Frame: From start of anaesthesia to 30 days after surgery
Pneumonia
From start of anaesthesia to 30 days after surgery
Surgical site infection
Time Frame: From end of anaesthesia to 30 days after surgery
Surgical site infection (superficial or deep)
From end of anaesthesia to 30 days after surgery
Urinary tract infection
Time Frame: From end of anaesthesia to 30 days after surgery
Urinary tract infection
From end of anaesthesia to 30 days after surgery
Infektion, source unknown
Time Frame: From end of anaesthesia to 30 days after surgery
Infektion, source unknown.
From end of anaesthesia to 30 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jan Pallesen, MD, Randers Regional Hospital
  • Principal Investigator: Rajesh Bhavsar, MD, Aabenraa Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 7, 2018

Primary Completion (Actual)

September 1, 2020

Study Completion (Actual)

September 1, 2020

Study Registration Dates

First Submitted

February 20, 2018

First Submitted That Met QC Criteria

April 17, 2018

First Posted (Actual)

April 18, 2018

Study Record Updates

Last Update Posted (Actual)

April 30, 2021

Last Update Submitted That Met QC Criteria

April 27, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • PreOPFOCUS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Protocol and statistical plan will be published in a peer-reviewed journal. Study results will be made available at a freely accessible online site.

IPD Sharing Time Frame

Protocol within 6 months of study commencement Study results within 6 months of study termination

IPD Sharing Access Criteria

Public

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on FOCUS (focused cardiac ultrasound)

3
Subscribe